Majority (53%) of the companies are located in Europe, followed by those located in North America (38%). Notable examples of companies located in Europe include (in alphabetical order) Biopharm, BlueSens, Eppendorf, and Kuhner. It is worth mentioning that majority (45%) of the companies based in Europe are small players, followed by mid-sized firms (28%).
Further, process analytical technologies (52) captures the maximum share of the digital biomanufacturing market, followed by manufacturing execution systems (34), data analysis software (17) and digital twins (11). Moreover, the market for PAT providers is currently dominated by the presence of small players (20), followed by mid-sized firms (13). It is worth highlighting that 35% of small companies were established post-2015 that are spearheading the innovation in this domain. Notable examples include (in reverse chronological order of their establishment) GenSensor (2021), Qubicon (2020), KYNOTA (2020) and Xenomics (2020).
Get more details on the Digital Biomanufacturing Market report https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
In fact, most of the PAT-based platforms engaged in digital biomanufacturing are capable of performing process automation (90%), followed by bioprocess optimization and controls (86%) and process connectivity solutions (81%). It is worth highlighting that 16% of process analytical technologies are capable of offering more than six platform capabilities. Notable examples include (in alphabetical order) MARTA (developed by Bionet), CellPort POWR (developed by CellPort), and Zenon (developed by Copa Data).
Most of the companies engaged in this domain offer on-premises deployment option (52%), followed by those providing cloud-based deployment option (40%). It is important to highlight that 21% of the firms offering cloud-based services for biomanufacturing are emerging start-ups that are established post-2015. Further, most of the companies engaged in this domain offer PAT platforms that facilitate the manufacturing of proteins (53%), followed by antibodies (42%) and cell therapies (26%). Notable examples of platforms offering protein manufacturing services include (in alphabetical order) Apollo X (developed by FUJIFILM Diosynth Biotechnologies), Integrated Continuous Bioprocessing (developed by Transcenta), MiD ProteinID (developed by Microsaic Systems) and SYMPHONX (developed by FUJIFILM Diosynth Biotechnologies).
Request a sample copy of the Digital Biomanufacturing Market report https://www.rootsanalysis.com/reports/digital-biomanufacturing-market/request-sample.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
